Eurasian Journal of Medical and Natural Sciences 5-jild 10-son (2025) · 13–20-betlar

THE ROLE OF PHOTOBIOMODULATION IN THE COMPLEX TREATMENT OF MYASTHENIA GRAVIS: ITS IMPACT ON THERAPEUTIC OUTCOMES AND IMMUNO-INFLAMMATORY MARKERS

Панжиева, Н.Н., Хайдаров, Н.К., Курбанов, Г.И.

DOI: 10.5281/zenodo.17285862 · Manbada o'qish →

Annotatsiya

Myasthenia gravis is a chronic autoimmune disorder characterized by impaired neuromuscular transmission, which leads to muscle weakness, rapid fatigability, and the risk of life-threatening complications. Despite advances in pharmacological therapy, there remains a need for additional approaches that can improve treatment efficacy, reduce side effects, and enhance patients’ quality of life. One of the promising directions is photobiomodulation (PBM), a physiotherapeutic method based on the use of low-intensity laser or LED irradiation. In recent years, PBM has been actively studied in neurology and immunology due to its ability to modulate mitochondrial activity, reduce inflammatory responses, and support cognitive functions. This paper discusses the potential mechanisms and clinical effects of PBM in myasthenia gravis, as well as its possible impact on immuno-inflammatory markers associated with disease activity.

myasthenia gravis, photobiomodulation, immuno-inflammatory markers, cognitive functions, non-pharmacological therapyмиастения гравис, фотобиомодуляция, иммуновоспалительные маркеры, когнитивные функции, немедикаментозная терапия.miasteniya gravis, fotobiomodulyatsiya, immun-yallig‘lanish markerlari, kognitiv funksiyalar, dori vositalarisiz davolash.

Metadata manbasi: jurnal OAI-PMH arxivi · Sindex to'liq matnni saqlamaydi, manbaga havola beradi.